Abstract
Central serous chorioretinopathy typically has a benign behavior, with spontaneous improvement within 3 months. For chronic and recurrent cases, there are several therapeutic alternatives and, among them, the micropulsed subthreshold laser stands out with good functional and anatomical results, in addition to a satisfactory safety profile. However, the lack of standardization is still a m…